GGrantIndex
← Leaderboards

Thomas E Shenk

Princeton University

$22,676,449
Attributed
$24,983,432
Total exposure
24
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$37,343,000 · 26

By mechanism

R01$19,817,579 · 8
P01$12,843,604 · 6
P50$2,396,385 · 2
R37$1,123,628 · 1
R21$445,500 · 1
R56$399,362 · 1

Top collaborators

Most similar at Princeton University

Same institution · by research overlap

Others in their field

Top investigators on “Cytomegalovirus

Research focus

CytomegalovirusCellsInfectionViralHerpesviridaeVirusCytomegalovirus InfectionsProgramsLaboratoriesCongenital AbnormalityProteinsVirionLifePathogenesisHost Organism InteractionGenesFibroblastsResponseAdultGene ExpressionBiochemicalCodeCell TypeProteomics

Grant awards (104)

An experimental system designed to identify human cytomegalovirus-induced alterations in tumor cells and test their dependence on continued viral gene expression$243,000
R21 · FY2020 · AI · contact PI
Viral Modulation of Epigenetic Mechanisms$483,000
R01 · FY2019 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$398,800
R01 · FY2019 · AI · contact PI
An experimental system designed to identify human cytomegalovirus-induced alterations in tumor cells and test their dependence on continued viral gene expression$202,500
R21 · FY2019 · AI · contact PI
Viral Modulation of Epigenetic Mechanisms$483,000
R01 · FY2018 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$398,800
R01 · FY2018 · AI · contact PI
Viral Modulation of Epigenetic Mechanisms$483,000
R01 · FY2017 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$398,800
R01 · FY2017 · AI · contact PI
Viral Modulation of Epigenetic Mechanisms$483,000
R01 · FY2016 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$398,800
R01 · FY2016 · AI · contact PI
Mechanisms and consequences of metabolic manipulation by human cytomegalovirus$554,306
R01 · FY2015 · AI
Viral Modulation of Epigenetic Mechanisms$498,000
R01 · FY2015 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$162,551
R01 · FY2015 · AI · contact PI
Mechanisms and consequences of metabolic manipulation by human cytomegalovirus$554,306
R01 · FY2014 · AI
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins$399,362
R56 · FY2014 · AI · contact PI
Human cytomegalovirus latency in cultured monocytes$358,628
R01 · FY2014 · AI · contact PI
Mechanisms and consequences of metabolic manipulation by human cytomegalovirus$521,048
R01 · FY2013 · AI
Human cytomegalovirus latency in cultured monocytes$337,110
R01 · FY2013 · AI · contact PI
Human Cytomegalovirus Tegument Proteins$334,181
R01 · FY2013 · CA · contact PI
PROJECT 3$234,261
P50 · FY2013 · GM · contact PI
Mechanisms and consequences of metabolic manipulation by human cytomegalovirus$554,306
R01 · FY2012 · AI
Human cytomegalovirus latency in cultured monocytes$358,628
R01 · FY2012 · AI · contact PI
Human Cytomegalovirus Tegument Proteins$355,512
R01 · FY2012 · CA · contact PI
PROJECT 3$243,230
P50 · FY2012 · GM · contact PI
Human cytomegalovirus latency in cultured monocytes$358,628
R01 · FY2011 · AI · contact PI
Human Cytomegalovirus Tegument Proteins$355,512
R01 · FY2011 · CA · contact PI
PROJECT 3$240,187
P50 · FY2011 · GM · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$6,518
P41 · FY2011 · RR · contact PI
Human Cytomegalovirus Tegument Proteins$366,508
R01 · FY2010 · CA · contact PI
Human cytomegalovirus latency in cultured monocytes$347,003
R01 · FY2010 · AI · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$299,209
R01 · FY2010 · CA · contact PI
PROJECT 3$244,619
P50 · FY2010 · GM · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$46,548
P41 · FY2010 · RR · contact PI
Human Cytomegalovirus Tegument Proteins$366,508
R01 · FY2009 · CA · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$299,209
R01 · FY2009 · CA · contact PI
Human Cytomegalovirus G Protein-Coupled Receptors$293,932
R01 · FY2009 · AI · contact PI
PROJECT 3$240,849
P50 · FY2009 · GM · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$172,564
R01 · FY2009 · CA · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$71,127
P41 · FY2009 · RR · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$24,885
R01 · FY2009 · CA · contact PI
Human Cytomegalovirus Tegument Proteins$349,837
R01 · FY2008 · CA · contact PI
Global Genetics Analysis of Human Cytomegalovirus$330,673
R01 · FY2008 · AI · contact PI
Host Virus Interaction$309,541
P50 · FY2008 · GM · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$299,209
R01 · FY2008 · CA · contact PI
Human Cytomegalovirus G Protein-Coupled Receptors$293,932
R01 · FY2008 · AI · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$58,976
R01 · FY2008 · CA · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$44,285
P41 · FY2008 · RR · contact PI
Human Cytomegalovirus Tegument Proteins$349,837
R01 · FY2007 · CA · contact PI
Global Genetics Analysis of Human Cytomegalovirus$337,077
R01 · FY2007 · AI · contact PI
Host Virus Interaction$306,553
P50 · FY2007 · GM · contact PI
Human Cytomegalovirus G Protein-Coupled Receptors$299,625
R01 · FY2007 · AI · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$299,209
R01 · FY2007 · CA · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$75,280
P41 · FY2007 · RR · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$34,091
R01 · FY2007 · CA · contact PI
Human Cytomegalovirus Tegument Proteins$360,285
R01 · FY2006 · CA · contact PI
Global Genetics Analysis of Human Cytomegalovirus$347,145
R01 · FY2006 · AI · contact PI
Human Cytomegalovirus G Protein-Coupled Receptors$308,574
R01 · FY2006 · AI · contact PI
Cytomegalovirus Immediate Early Proteins and Virion RNAs$308,145
R01 · FY2006 · CA · contact PI
Host Virus Interaction$197,039
P50 · FY2006 · GM · contact PI
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$49,392
P41 · FY2006 · RR · contact PI
Human Cytomegalovirus Tegument Proteins$368,955
R01 · FY2005 · CA
Global Genetics Analysis of Human Cytomegalovirus$355,500
R01 · FY2005 · AI
Human Cytomegalovirus G Protein-Coupled Receptors$316,000
R01 · FY2005 · AI
Host Virus Interaction$192,336
P50 · FY2005 · GM
FOLLOWING THE FATE OF HCMV GENE PRODUCTS IN HOST CELLS$23,792
P41 · FY2005 · RR
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$2,253,193
P01 · FY2004 · CA
Human Cytomegalovirus Tegument Proteins$368,955
R01 · FY2004 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$310,032
R01 · FY2004 · CA
Host Virus Interaction$187,770
P50 · FY2004 · GM
Global Genetics Analysis of Human Cytomegalovirus$118,500
R01 · FY2004 · AI
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$78,594
R01 · FY2004 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$2,191,190
P01 · FY2003 · CA
HUMAN CYTOMEGALOVIRUS TEGUMENT PROTEINS$370,248
R01 · FY2003 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$310,032
R01 · FY2003 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$114,915
R01 · FY2003 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$2,130,169
P01 · FY2002 · CA
STRUCTURE AND FUNCTION OF DNA TUMOR VIRUS GENOMES$385,667
R37 · FY2002 · CA
HUMAN CYTOMEGALOVIRUS TEGUMENT PROTEINS$360,088
R01 · FY2002 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$310,032
R01 · FY2002 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$112,028
R01 · FY2002 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$36,408
R01 · FY2002 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$14,854
P01 · FY2002 · CA
CORE--TECHNICAL AND BIOINFORMATICS SUPPORT$0
P01 · FY2002 · CA
CORE--TECHNICAL AND BIOINFORMATICS SUPPORT$0
P01 · FY2002 · CA
HUMAN CYTOMEGALOVIRUS REPLICATION AND LATENCY$0
P01 · FY2002 · CA
HUMAN CYTOMEGALOVIRUS REPLICATION AND LATENCY$0
P01 · FY2002 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$2,056,092
P01 · FY2001 · CA
STRUCTURE AND FUNCTION OF DNA TUMOR VIRUS GENOMES$374,434
R37 · FY2001 · CA
HUMAN CYTOMEGALOVIRUS TEGUMENT PROTEINS$350,228
R01 · FY2001 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$310,032
R01 · FY2001 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$42,513
P01 · FY2001 · CA
CORE--TECHNICAL AND BIOINFORMATICS SUPPORT$0
P01 · FY2001 · CA
CORE--TECHNICAL AND BIOINFORMATICS SUPPORT$0
P01 · FY2001 · CA
HUMAN CYTOMEGALOVIRUS REPLICATION AND LATENCY$0
P01 · FY2001 · CA
HUMAN CYTOMEGALOVIRUS REPLICATION AND LATENCY$0
P01 · FY2001 · CA
HERPESVIRUS PERSISTENCE AND ONCOGENICITY$2,168,305
P01 · FY2000 · CA
VIRAL AND CELLULAR ONCOGENES--MECHANISM OF ACTION$1,503,252
P01 · FY2000 · CA
STRUCTURE AND FUNCTION OF DNA TUMOR VIRUS GENOMES$363,527
R37 · FY2000 · CA
HUMAN CYTOMEGALOVIRUS TEGUMENT PROTEINS$340,651
R01 · FY2000 · CA
CYTOMEGALOVIRUS IMMEDIATE EARLY PROTEINS AND VIRION RNAS$310,032
R01 · FY2000 · CA
CORE COMPONENT$242,018
P01 · FY2000 · CA
AD5 E1B TRANSFORMING GENE AND ESTROGEN-DEPENDENT BREAST TUMOR INDUCTION BY AD9$242,018
P01 · FY2000 · CA
HUMAN CYTOMEGALOVIRUS REPLICATION AND LATENCY$0
P01 · FY2000 · CA
CORE--TECHNICAL AND BIOINFORMATICS SUPPORT$0
P01 · FY2000 · CA